National Tuberculosis (TB) Control and Prevention Program in Medina City

Abstract

The National Tuberculosis (TB) Control and Prevention Program in Medina City implements a comprehensive strategy to address TB, aligning with international guidelines set by the American Thoracic Society, the Centers for Disease Control and Prevention (CDC), and the Infectious Diseases Society of America (IDSA), emphasizing evidence-based approaches for TB management and diagnosis. The program differentiates recommendations based on patients' risk levels, employing Interferon-Gamma Release Assays (IGRA) as the preferred diagnostic method over Tuberculin Skin Tests (TST) for certain age groups and BCG-vaccinated individuals. For active TB diagnosis, the program uses Acid-Fast Bacilli (AFB) smear microscopy combined with mycobacterial cultures and Nucleic Acid Amplification Testing (NAAT), allowing rapid identification and assessment of drug-resistant strains. Treatment and prevention measures include Directly Observed Treatment, Short-course (DOTS) to enhance medication adherence, free access to second-line drugs for multidrug-resistant TB, and proactive monitoring of treatment side effects to ensure patient compliance.
Preventive strategies, such as the BCG vaccination for infants, stringent infection control in healthcare settings, public awareness initiatives, and regular screenings for high-risk groups, play pivotal roles in reducing TB transmission. The program emphasizes targeted testing and treatment of latent TB infections, leveraging a combination of IGRA and TST methods tailored to each patient’s needs. Through extensive surveillance and data collection, Medina’s program identifies treatment gaps, tracks drug resistance trends, and informs resource allocation. Moreover, the program collaborates with international organizations, focusing on research, capacity building, and addressing social determinants influencing TB transmission. These efforts illustrate Medina’s commitment to TB elimination by integrating diagnostic, preventive, and treatment strategies within a robust public health framework.